EKF Diagnostics Investor Announcements
EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.
Capitalised terms in this announcement carry the same meaning as in the RNS of 28 September 2021, unless otherwise stated
Texas based CLIA lab acquired, specialising in COVID-19 PCR testing.
Further upgrade to current year trading.
Full year performance expected to be in-line with management expectations.
Appointment of Investec Bank plc as joint corporate broker, with immediate effect to work alongside its existing nominated adviser and broker, N+1 Singer.
Presentation to institutional investors by Julian Baines and Mike Salter.
Update on Fundraising and Admission by Trellus Health.
Launch of Restricted Offer on behalf of Trellus Health.